|Last Price$27.74||Day Change (%)-0.14%|
|Open Price$27.66||Day Change ($)-0.04|
|Day Range27.66–27.74||52-Week Range24.75–28.61|
As of Mon 6/27/2016 1:29:00 PM | USD
Palisades Hudson Newsletter: http://palisadeshudson.com/sentinel/ Larry Elkin's Blog: http://palisadeshudson.com/current-commentary/
Sokol's resignation clouds Berkshire's succession plan, while his Lubrizol trades tarnish to some extent the firm's legacy of strong ethical behavior.
Noninsurance operations continue to be a source of stability, while its insurance business overall may see more meager results during the next couple of years.
Quarterly results were an improvement on prior-year earnings, though book value per share came in lower than we expected.
Berkshire's non-insurance operations continue to be an added source of stability while reinsurance operations continue to struggle.
Wide-moat Berkshire Hathaway saw solid top-line results from each of its main segments, but losses from investments, derivatives, and eliminations sent earnings lower.
2013 results once again demonstrate the value of Berkshire's diversified portfolio, as solid and consistent performance from the firm's non-insurance operations helped smooth out some of the volatility seen in its insurance businesses.
Alternative methods have some use, but we think discounted cash flow is the most fundamentally sound way to value the conglomerate, as we discuss in the final installment of our 5-part series.
Morningstar's Gregg Warren, who will be on the analyst panel at this year's meeting, details the questions he hopes Buffett and Munger will address.
Just about every segment at Berkshire was dealing with elevated costs during the first quarter.